ArticleBlood advances2022

Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report.

Vanessa A Fabrizio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.